XML 36 R17.htm IDEA: XBRL DOCUMENT
v3.26.1

TAXES ON INCOME | 12 Months Ended
--- | ---
Dec. 31, 2025
Disclosure Of Income Taxes [Abstract] |
TAXES ON INCOME | NOTE 12 – TAXES ON INCOME
| a. | Corporate taxation
The taxable income of BioLineRx Ltd. and Tetragon is taxed at the standard Israeli corporate tax rate, which was 23% for all years included in these financial statements.
| b. | Tax loss carryforwards
As of December 31, 2025, the tax loss carryforwards of BioLineRx Ltd. were approximately $381 million. The tax loss carryforwards have no expiration date.
| c. | Tax assessments
In accordance with Israeli tax regulations, the tax returns filed by BioLineRx Ltd. through the 2020 tax year are considered final.
| d. | Theoretical taxes
The Company has not recognized any deferred tax assets in the financial statements, as it does not expect to generate taxable income in the foreseeable future. The reported tax on the Company’s income before taxes differs from the theoretical amount that would arise using the weighted average tax rate applicable to income of the consolidated entities as follows:
|  | Year ended December 31, |
|  | 2023 |  |  | 2024 |  |  | 2025 |
|  |  |  |  | in USD |  |  |  |  |  | in USD |  |  |  |  |  | in USD |
|  |  |  |  | thousands |  |  |  |  |  | thousands |  |  |  |  |  | thousands |
Loss before taxes |  |  | 23.0 | % |  |  | (60,614 | ) |  |  | 23.0 | % |  |  | (9,221 | ) |  |  | 23.0 | % |  |  | (2,026 | )
Theoretical tax benefit |  |  |  |  |  |  | (13,941 | ) |  |  |  |  |  |  | (2,121 | ) |  |  |  |  |  |  | (466 | )
Disallowed deductions (tax exempt income): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loss (gain) on adjustment of warrants to fair value |  |  |  |  |  |  | 2,542 |  |  |  |  |  |  |  | (4,056 | ) |  |  |  |  |  |  | (1,978 | )
Share-based compensation |  |  |  |  |  |  | 534 |  |  |  |  |  |  |  | 261 |  |  |  |  |  |  |  | 91 |
Impairment of intangible asset |  |  |  |  |  |  | 1,542 |  |  |  |  |  |  |  | 232 |  |  |  |  |  |  |  | - |
Other |  |  |  |  |  |  | 11 |  |  |  |  |  |  |  | 11 |  |  |  |  |  |  |  | 11 |
Increase in taxes for tax losses and timing differences incurred in the reporting year for which deferred taxes were not created |  |  |  |  |  |  | 9,312 |  |  |  |  |  |  |  | 5,673 |  |  |  |  |  |  |  | 2,342 |
Taxes on income for the reported year |  |  |  |  |  |  | - |  |  |  |  |  |  |  | - |  |  |  |  |  |  |  | - |

X
- References No definition available. + Details
Name: | blrx_DisclosureOfIncomeTaxesAbstract
Namespace Prefix: | blrx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income taxes. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 12 -IssueDate 2025-01-01 -Section Disclosure -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI -URIDate 2025-03-27 + Details
Name: | ifrs-full_DisclosureOfIncomeTaxExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration